Peptide Drug Interactions
59 interactions across 34 peptides, sorted by severity. Each page details the mechanism, evidence basis, and clinical context.
contraindicated documented theoretical
| Peptide | Drug / Class | Classification |
|---|---|---|
| GHRP-2 | Somatostatin analogs | contraindicated |
| GHRP-6 | Somatostatin analogs | contraindicated |
| CJC-1295 | glucocorticoids | documented |
| GHRP-2 | Glucocorticoids | documented |
| GHRP-6 | Glucocorticoids | documented |
| Hexarelin | Glucocorticoids | documented |
| Ipamorelin | glucocorticoids | documented |
| Ipamorelin | somatostatin analogs | documented |
| Kisspeptin-10 | GnRH agonists/antagonists | documented |
| Melanotan-II | PDE5 inhibitors (sildenafil, tadalafil) | documented |
| MK-677 | Insulin / oral hypoglycemics | documented |
| Nad+ | alcohol | documented |
| PT-141 | antihypertensives | documented |
| Retatrutide | Insulin | documented |
| Retatrutide | Sulfonylureas | documented |
| Semaglutide | insulin | documented |
| Semaglutide | sulfonylureas | documented |
| Sermorelin | glucocorticoids | documented |
| Tesamorelin | Glucocorticoids | documented |
| Thymosin-Alpha-1 | immunosuppressants | documented |
| Tirzepatide | Insulin | documented |
| Tirzepatide | Sulfonylureas | documented |
| VIP | Antihypertensives | documented |
| 5-Amino-1mq | NNMT substrates | theoretical |
| AOD-9604 | Growth hormone | theoretical |
| BPC-157 | NSAIDs | theoretical |
| BPC-157 | anticoagulants | theoretical |
| Cerebrolysin | Antidepressants | theoretical |
| Cerebrolysin | MAO inhibitors | theoretical |
| CJC-1295 | insulin | theoretical |
| Dihexa | ACE inhibitors | theoretical |
| DSIP | Sedatives / hypnotics | theoretical |
| Epitalon | Immunosuppressants | theoretical |
| Fox04-DRI | Chemotherapy agents | theoretical |
| GHK-CU | Copper supplements | theoretical |
| Hexarelin | Beta-blockers | theoretical |
| Kisspeptin-10 | Hormonal contraceptives | theoretical |
| KPV | Immunosuppressants | theoretical |
| LL-37 | Immunosuppressants | theoretical |
| Melanotan-II | Antihypertensives | theoretical |
| MK-677 | Glucocorticoids | theoretical |
| MOTS-C | Insulin | theoretical |
| MOTS-C | Metformin | theoretical |
| Nad+ | chemotherapy | theoretical |
| PT-141 | naltrexone | theoretical |
| Retatrutide | Oral medications | theoretical |
| Selank | Benzodiazepines | theoretical |
| Selank | SSRIs / SNRIs | theoretical |
| Semaglutide | oral contraceptives | theoretical |
| Semax | SSRIs | theoretical |
| Semax | stimulants | theoretical |
| Sermorelin | insulin | theoretical |
| SS-31 | Mitochondrial-targeted therapies | theoretical |
| TB-500 | anticoagulants | theoretical |
| Tesamorelin | Insulin / oral hypoglycemics | theoretical |
| Thymosin-Alpha-1 | interferons | theoretical |
| Thymosin-BETA-4 | Anticoagulants | theoretical |
| Tirzepatide | Oral contraceptives | theoretical |
| VIP | Phosphodiesterase inhibitors | theoretical |